Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials

Overview of attention for article published in Neurology, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 1 news outlet
twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 74 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Professor Yasser Metwally...www.yassermetwally.com, 06 Apr 2015

Objective: Prevention trials for neurodegenerative diseases use genetic or other risk marker tests to select participants but…